AMEX · BMED
iShares Health Innovation Active ETF
$36.49-$0.23 (-0.63%)
iShares Health Innovation Active ETF’s quoted price sits in the upper half of its reported 52-week range, 1.33% below the high.
Loading market information…
AMEX · MIDE · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Xtrackers S&P MidCap 400 Scored & Screened ETF’s quoted price sits in the upper half of its reported 52-week range, 5.46% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Xtrackers S&P MidCap 400 Scored & Screened ETF’s forward annual dividend is $0.52 per share, paid quarterly. The forward yield is 1.4% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
MIDE adds an ESG layer to the S&P mid-cap 400. It seeks to capture US mid-caps with high ESG scores within each GICS sector, while maintaining the sector weights of the S&P 400. MIDE screens out companies involved in tobacco, controversial weapons and thermal coal. Companies are also excluded if they fall in the bottom 5% of the United Nations Global Compact (UNGC) score ranking or in the bottom 25% of ESG scores within each GICS sector as rated by SAM. Inclusion of constituents flagged for risks involving controversial issues is subject for review by the Index Committee. The index is market cap-weighted and rebalances on an annual basis. On February 10, 2025, both the fund and its index dropped and replaced ESG name claims with Scored and Screened. The change has no effect on the funds strategy.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Nov 1, 2026, 03:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$36.49-$0.23 (-0.63%)
iShares Health Innovation Active ETF’s quoted price sits in the upper half of its reported 52-week range, 1.33% below the high.
$65.86-$4.04 (-5.78%)
ProShares - Nanotechnology ETF’s quoted price sits in the lower half of its reported 52-week range, 32.19% below the high.
$33.30+$0.01 (+0.02%)
iShares Neuroscience and Healthcare ETF’s quoted price sits in the lower half of its reported 52-week range, 22.59% below the high.
$12.94+$0.02 (+0.19%)
Fundamentals First ETF’s quoted price sits in the upper half of its reported 52-week range, 2.63% below the high.
$24.77-$0.61 (-2.41%)
Virtus Duff & Phelps Clean Energy ETF’s quoted price sits in the lower half of its reported 52-week range, 34.03% below the high.
$53.01$0.00 (0.0%)
ProShares - Russell U.S. Dividend Growers ETF’s quoted price sits in the upper half of its reported 52-week range, 1.87% below the high.
$31.53+$0.41 (+1.3%)
First Trust IPOX Europe Equity Opportunities ETF’s quoted price sits in the lower half of its reported 52-week range, 14.03% below the high.
$27.37-$0.23 (-0.82%)
Alliance Bernstein - AB International Growth ETF’s quoted price sits in the lower half of its reported 52-week range, 10.14% below the high.
